Costa said Novo Nordisk is not concerned about the patent expiration, as it is a normal process in the pharmaceutical industry. The executive also minimized the potential effects of the global trade ...

Drug maker Novo Nordisk (NVO), on Monday, warned consumers about counterfeit versions of its diabetes drug Ozempic in the U.S ...